Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...

A newly identified mechanism lends credence to the idea that MS may be treatable by targeting EBV-infected B-cells, a study found.

Researchers at Oregon Health & Science University have identified a type of enzyme with a complicated name - cell migration inducing and hyaluronan-binding protein, or CEMIP - is associated with ...

A new technique is letting scientists peer into the brain’s wiring with greater detail by simply using a microscope and an LED light, an accessible and cost-effective method that may be useful for ...

Researchers from Tel Aviv University have discovered a new biological mechanism that boosts the production of myelin - the fatty substance that insulates nerve fibers (axons) and enables rapid, ...

The laminin-411 protein is vital for the formation of the myelin membrane by oligodendrocytes, report researchers from Japan. Furthermore, the A4G47 peptide from the E8 region of laminin-411 was found ...

Researchers at Institute of Science Tokyo have identified laminin-411 and A4G47, a synthetic peptide derived from the E8 domain of laminin-411 protein, as the key factors in the maturation of ...

There has been a growing interest in the role of oligodendrocytes (OLs) and the myelin sheaths they form around axons in cognitive function. Historically, OLs were primarily considered to be involved ...

Oligodendrocytes form myelin sheath during CNS development (developmental myelination). New concepts have emerged on the role of oligodendroglia and myelination in shaping animal life experience such ...

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and stability of myelin, suggesting an important impact on neurodegenerative diseases ...

HOUSTON, April 02, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of ...